Munich RE


Good 2020 results in COVID times, strong January renewals

25/02/21 -"• Net profit attributable to shareholders decreased by 56% to €1.21bn for 2020 but was in line with the revised company guidance • COVID-19-related losses were €3.5bn in FY2020 • The dividend ..."

Pages
59
Language
English
Published on
25/02/21
You may also be interested by these reports :
16/11/26
Generali’s 3Q26 results came in slightly below expectations, notably in Property & Casualty (P&C), although underlying performance appears resilient ...

16/11/26
Following Generali’s 3Q26 results and conference call, we have cut our net profit estimates by c. 1% for FY26 and c. 2% for FY27. The downgrade ...

13/11/26
Five years on, European insurers have plainly struck gold. Whether the sharp 2022 rate rises aimed at taming post-Covid inflation lit the fuse is ...

13/11/26
Generali has released 3Q26 results slightly below expectations, though we believe this is partly due to higher-than-expected natural catastrophe and ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO